Sullivan Lynne Marie 4
4 · Inozyme Pharma, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Sullivan Lynne Marie
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-13+16,000→ 16,000 totalExercise: $6.18Exp: 2033-06-12→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 13, 2023. The shares underlying the option are scheduled to vest as to 100% of the shares on June 13, 2024, or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date.